Letter: Further risk with bleomycin.
D000328:Adult; D001761:Bleomycin / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular / Q000009:adverse effects; D008113:Liver Neoplasms / Q000188:drug therapy*; D008545:Melanoma / Q000601:surgery; D009336:Necrosis / Q000209:etiology; D009362:Neoplasm Metastasis; D012878:Skin Neoplasms / Q000601:surgery
D001761:Bleomycin